Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance?

  • George Kunos*
  • , Tony Jourdan
  • , Joseph Tam
  • *Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

3 Scopus citations
Original languageEnglish
Article numbere155330
JournalJournal of Clinical Investigation
Volume132
Issue number1
DOIs
StatePublished - 4 Jan 2022

Cite this